ARCHIVES

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

This article is from The Cancer Letter archive.

Vol. 07 No. 21 | May 22, 1981

Download PDF Visit The Full Archive

Related Articles

ORI Finds Misconduct By Two Researchers

December 8, 1995

BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.

February 25, 2000

Researchers Identify Five Genes Associated With Melanoma Risk

July 29, 2011

Colonoscopy Every Three Years Indicated For Those With Family History Of Polyps

May 31, 2002

In Brief: Breast Cancer Coalition Seeks Survivors, Activists For 3-Day Course In Advocacy

April 28, 1995

MDV3100 Improves Survival, Reduces Death Risk by 37%

November 25, 2011